$ Value
—
Shares
6,755
Price
—
Filed
May 20
Insider
Name
Galvin Roy
Title
President, Global Plasma & BC
CIK
0001950021
Roles
Transaction Details
Transaction Date
2025-05-16
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
13,998
Footnotes
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. | This number includes unvested RSUs previously reported. | Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.